David Joyner, CVS Health CEO (AP Photo/Carolyn Kaster)
February 12, 2025 01:34 PM ESTUpdated 02:57 PM
Financing
Health Tech

High med­ical costs have eat­en away at CVS Health's earn­ings all year. There’s no quick fix

Shelby Livingston

Senior health tech reporter

CVS Health end­ed 2024 as it start­ed, with high med­ical costs in the com­pa­ny’s in­sur­ance busi­ness chip­ping away at its bot­tom line.

The health­care gi­ant …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Ab­b­Vie pens an­oth­er T cell en­gager deal, this time with Xilio

Bio­gen down­plays ca­pac­i­ty for M&A; Roche’s SMA drug is ap­proved as a tablet

Anap­tys­Bio gets a mid-stage win for PD-1 drug in rheuma­toid arthri­tis

Ma­jor FDA staff cuts would slow drug re­views, ex­perts say

Bio­gen gets $250M in Roy­al­ty Phar­ma deal for Phase 3 lu­pus pro­gram

sponsored

Re­duc­ing risk in drug de­vel­op­ment: The im­por­tance of val­i­dat­ed MRD test­ing in lym­phoid can­cers

A service from the Financial Times